TP53 and oligodendroglioma: In contrast, IDH1/2-mutant astrocytoma cases demonstrated high p53 (90.7%) and low cell cycle (24.4%) activation, while oligodendroglioma cases showed minimal activation of both pathways (15.1% and 5.7%, respectively).